Description
ETROVIS-120
is a fast-acting pain relief tablet formulated by ANVIS Laboratories, containing Etoricoxib 120mg per dose. Etoricoxib is a selective COX-2 inhibitor that effectively reduces inflammation and pain without causing significant gastrointestinal side effects, making it ideal for patients with chronic back pain, osteoarthritis, and musculoskeletal disorders.
Each box contains 10 tablets, designed for short-term or intermittent use under medical supervision. The product packaging features a spine illustration, emphasizing its targeted action for spinal and lower back discomfort. ETROVIS-120 is known for its rapid onset of action and long-lasting effect, providing relief within hours and maintaining comfort throughout the day.
Recommended for adults suffering from acute pain episodes, ETROVIS-120 should be taken once daily or as prescribed. It is not suitable for individuals with severe cardiovascular conditions or active ulcers. The tablet is manufactured to high pharmaceutical standards and is part of ANVIS’s trusted pain management portfolio.
